Comanche Biopharma
PrivateLast Round
VC Round
Jan 5, 2026
Total Funding Raised
$111.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Comanche Biopharma Comparables
Compare Comanche Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MirZyme Therapeutics | 86% | |
| DiaMedica Therapeutics Inc. | 67% | |
| Evergreen Therapeutics, Inc. | 63% | |
Comanche Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 5, 2026 | ||||
| Series B | Jan 17, 2024 | ||||
| Series A | Jun 28, 2021 |
Key People
Founding team and executive leadership
Comanche Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, VC Round, Series B |
| New Enterprise Associates (NEA) | VC Round, Series B |
| F-Prime Capital | Series A, Series B |
| Longview Healthcare Ventures | Series A, VC Round, Series B |
| F-Prime Capital | VC Round, Series B, Series A |
| Lilly Asia Ventures | Series A, VC Round, Series B |
| Atlas Venture | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2026
Open roles increased to 10, doubling the trailing average.
- Aug 22, 2026
Monthly visitors grew 72% MoM, reaching 3K.
Comanche Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Comanche Biopharma's valuation, stock price, and market status.